Hot-selling N-(4-Aminobenzoyl)-L-glutamic acid - trans-1,4-Dibromo-2-butene CAS 821-06-7 Purity ≥99.0% (GC) – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
Hot-selling N-(4-Aminobenzoyl)-L-glutamic acid - trans-1,4-Dibromo-2-butene CAS 821-06-7 Purity ≥99.0% (GC) – Ruifu Detail:

Manufacturer with High Quality and Competitive Price
Commercial Supply Aliskiren Related Intermediates:
Aliskiren CAS: 173334-57-1
Aliskiren Hemifumarate CAS: 173334-58-2
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R)-4-Benzyl-2-Oxazolidinone CAS: 102029-44-7
trans-1,4-Dibromo-2-Butene CAS: 821-06-7
Isovaleryl Chloride CAS: 108-12-3
D-Phenylalanine CAS: 673-06-3
D-Phenylalaninol CAS: 5267-64-1

Chemical Name trans-1,4-Dibromo-2-Butene
Synonyms (E)-1,4-Dibromobut-2-ene; (2E)-1,4-Dibromo-2-butene
CAS Number 821-06-7
CAT Number RF-PI149
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C4H6Br2
Molecular Weight 213.9
Solubility in Methanol Almost Transparency
Brand Ruifu Chemical
Item Specifications
Appearance White to Brown Solid
Purity / Analysis Method ≥99.0% (GC)
Cis Content ≤0.20%
Melting Point 50.0℃~54.0℃
Tetrabromobutane (TBB) ≤0.50%
Moisture (K.F) ≤0.20%
Test Standard Enterprise Standard
Usage Aliskiren and Aliskiren Hemifumarate Pharmaceutical Intermediate 

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis. 

trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) is a key intermediate in the synthesis of Aliskiren (CAS: 173334-57-1), API.

Aliskiren is a first-in-class antihypertensive drug that acts by direct inhibition of renin. It is indicated for oral administration either as monotherapy or in combination with other antihypertensive agents. Renin catalyzes the cleavage of angiotensin to form angiotensin I, the first and the rate-limiting step of the RAAS. The inhibition of renin by aliskiren results in reduced levels of angiotensin I, angiotensin II, and aldosterone, all of which contribute to the antihypertensive effect. RAAS modulators are among some of the most commonly prescribed antihypertensive agents to date.


Product detail pictures:

Hot-selling N-(4-Aminobenzoyl)-L-glutamic acid - trans-1,4-Dibromo-2-butene CAS 821-06-7 Purity ≥99.0% (GC)  – Ruifu detail pictures


Related Product Guide:

Hot-selling N-(4-Aminobenzoyl)-L-glutamic acid - trans-1,4-Dibromo-2-butene CAS 821-06-7 Purity ≥99.0% (GC) – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us